Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buggy, J. J.
Right arrow Articles by Rossomando, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buggy, J. J.
Right arrow Articles by Rossomando, A. J.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 46, Issue 9 1400-1405, Copyright © 1997 by American Diabetes Association

ARTICLES

Role of the glucagon receptor COOH-terminal domain in glucagon-mediated signaling and receptor internalization

JJ Buggy, RO Heurich, M MacDougall, KA Kelley, JN Livingston, H Yoo-Warren and AJ Rossomando
Bayer Corporation, West Haven, Connecticut 06516, USA.

The binding of glucagon to its hepatic receptor is known to result in a number of effects, including the intracellular accumulation of cAMP, the mobilization of intracellular Ca2+, and the endocytosis of glucagon and its receptor into intracellular vesicles. In this study, we begin to define the functional role of the COOH-terminal tail of the human glucagon receptor in glucagon-stimulated signal transduction and receptor internalization. We have created and expressed in Chinese hamster ovary (CHO) cells five truncation mutants in which the COOH-terminal 24, 56, 62, 67, and 73 amino acids have been removed. Cells expressing relevant truncated receptors were assayed for cell surface expression by immunofluorescence, for ligand-binding properties, for cAMP and Ca2+-mediated signal transduction properties, and for receptor endocytosis. In addition, a mutant receptor containing seven serine-to-alanine mutations in the COOH-terminal tail was studied. Our results reveal the following: 1) a region of the COOH-terminal tail that is required for proper cell surface expression, 2) the COOH-terminal 62 amino acids, which comprise the majority of the tail, are not required for ligand binding, cAMP accumulation, or Ca2+ mobilization, and 3) phosphorylation of the COOH-terminal tail is crucial for glucagon-stimulated receptor endocytosis.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J EndocrinolHome page
P. Vazquez, I. Roncero, E. Blazquez, and E. Alvarez
The cytoplasmic domain close to the transmembrane region of the glucagon-like peptide-1 receptor contains sequence elements that regulate agonist-dependent internalisation
J. Endocrinol., July 1, 2005; 186(1): 221 - 231.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. L. Estall, J. A. Koehler, B. Yusta, and D. J. Drucker
The Glucagon-like Peptide-2 Receptor C Terminus Modulates {beta}-Arrestin-2 Association but Is Dispensable for Ligand-induced Desensitization, Endocytosis, and G-protein-dependent Effector Activation
J. Biol. Chem., June 10, 2005; 280(23): 22124 - 22134.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
F. Authier, P. H. Cameron, C. Merlen, M. Kouach, and G. Briand
Endosomal Proteolysis of Glucagon at Neutral pH Generates the Bioactive Degradation Product Miniglucagon-(19-29)
Endocrinology, December 1, 2003; 144(12): 5353 - 5364.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
K. E. Mayo, L. J. Miller, D. Bataille, S. Dalle, B. Goke, B. Thorens, and D. J. Drucker
International Union of Pharmacology. XXXV. The Glucagon Receptor Family
Pharmacol. Rev., March 1, 2003; 55(1): 167 - 194.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. Horikawa, B. D. Gaylinn, C. E. Lyons Jr., and M. O. Thorner
Molecular Cloning of Ovine and Bovine Growth Hormone-Releasing Hormone Receptors: The Ovine Receptor Is C-Terminally Truncated
Endocrinology, June 1, 2001; 142(6): 2660 - 2668.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. B. Wheeler, R. W. Gelling, S. A. Hinke, B. Tu, R. A. Pederson, F. Lynn, J. Ehses, and C. H. S. McIntosh
Characterization of the Carboxyl-terminal Domain of the Rat Glucose-dependent Insulinotropic Polypeptide (GIP) Receptor. A ROLE FOR SERINES 426 AND 427 IN REGULATING THE RATE OF INTERNALIZATION
J. Biol. Chem., August 27, 1999; 274(35): 24593 - 24601.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. M. Cypess, C. G. Unson, C.-R. Wu, and T. P. Sakmar
Two Cytoplasmic Loops of the Glucagon Receptor Are Required to Elevate cAMP or Intracellular Calcium
J. Biol. Chem., July 2, 1999; 274(27): 19455 - 19464.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
W. G. Thomas, T. J. Motel, C. E. Kule, V. Karoor, and K. M. Baker
Phosphorylation of the Angiotensin II (AT1A) Receptor Carboxyl Terminus: A Role in Receptor Endocytosis
Mol. Endocrinol., October 1, 1998; 12(10): 1513 - 1524.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1997 by the American Diabetes Association.